FTH (FTH) Stock Price & Analysis
FTH (FTH) rose 2.69% to USD 40.05 as of September 8, 2026 at 06:20 UTC, according to Nexqual real-time market data.
FTH last closed at USD 40.05; the session ranged USD 38.35–41.16 on volume of 275,248 shares. Market capitalization is —, with a 52-week range of USD 7.45–41.16 (NCM). Source: Nexqual, September 8, 2026 at 06:20 UTC.
Key Statistics (as of September 8, 2026 at 06:20 UTC)
| Price | USD 40.05 |
|---|---|
| Change | ▲ 2.69% (up) |
| Previous Close | USD 40.05 |
| Open | USD 40.05 |
| Day Range | USD 38.35 – 41.16 |
| 52-Week Range | USD 7.45 – 41.16 |
| Volume | 275,248 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (FTH)
Nexqual's technical model rates FTH "BUY" based on 5 bullish and 3 bearish signals across 128 daily candles, as of September 8, 2026 at 06:20 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 73.27 (overbought) |
| vs SMA50 | Above (USD 29.85) |
| MACD | 2.64 (positive) |
From FTH's Latest SEC 10-K Filing (filed 2026-03-30)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SRZN | Surrozen, Inc. | USD 22.76 | ▲ 0.71% |
| TIL | Instil Bio, Inc. | USD 7.58 | ▼ 1.37% |
| VOR | Vor Biopharma Inc. | USD 25.05 | ▲ 1.17% |
| HOWL | Werewolf Therapeutics, Inc. | USD 0.97 | ▼ 3.18% |
| INAB | IN8bio, Inc. | USD 1.2 | ▲ 9.09% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:20 UTC. This page is informational and not investment advice.